Clinical Trial Update: PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated PTK/ZK as post-transplant maintenance therapy in patients with multiple myeloma; the study was terminated and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• PTK/ZK (vatalanib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2014-09-04